Outlook Therapeutics (NASDAQ:OTLK) shares were down 10% Thursday morning after the company said it had completed an analysis of the complete 12-week results for a study of its drug ONS-5010 in the ...

it’s unclear whether the NCAA’s previous rules regarding recruiting inducements and NIL would even be relevant under the new system. The House settlement is still awaiting final approval from ...